VF
LJPC

Virtu Financial’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Virtu Financial’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,258
Closed -$85K – 2488
2021
Q3 		$85K Buy
+21,258
New +$84.4K 0.01% 1188
2021
Q2 		– Sell
-11,843
Closed -$50K – 2434
2021
Q1 		$50K Sell
11,843
-19,384
-62% -$107K ﹤0.01% 1438
2020
Q4 		$121K Buy
+31,227
New +$133K 0.01% 1012
2020
Q3 		– Sell
-22,411
Closed -$95K – 1833
2020
Q2 		$95K Buy
+22,411
New +$136K 0.01% 899
2019
Q2 		– Sell
-10,475
Closed -$67K – 2124
2019
Q1 		$67K Buy
+10,475
New +$68.2K ﹤0.01% 1183
2018
Q1 		– Sell
-14,362
Closed -$462K – 3161
2017
Q4 		$462K Buy
14,362
+1,258
+10% +$41.1K 0.02% 895
2017
Q3 		$456K Buy
+13,104
New +$421K 0.02% 1009

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's LJPC Position: Q4 2021 in Review

Virtu Financial sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 21,258 shares — an estimated $85K sold.

Virtu Financial first reported a position in LJPC in Q3 2017 and held it in 7 quarters. The position peaked at $462K in Q4 2017. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • Virtu Financial reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • Virtu Financial sold 21,258 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $85K.
  • Virtu Financial first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 7 quarters.
  • Virtu Financial's La Jolla Pharmaceutical Company position peaked at $462K in Q4 2017.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.